bromocriptine has been researched along with Anochlesia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asselin, AA; Humber, LG; Metcalf, G; Voith, K | 1 |
| Ali, J; Baboota, S; Chuttani, K; Khan, RA; Md, S; Mustafa, G; Sahni, JK | 1 |
| Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F | 1 |
| Draganova, S; Georgiev, V; Getova, D; Lazarova, M; Markovska, V; Petkov, V; Petkova, B; Roussinov, K; Shopova, S | 1 |
| Araki, T; Itoyama, Y; Kobayashi, T; Ohta, T; Oshima, Y; Takeshita, M | 1 |
| Fukuzaki, K; Kamenosono, T; Nagata, R | 1 |
| Boissier, JR; Chermat, R; Puech, AJ; Simon, P | 1 |
| Onodera, K; Shinoda, H | 1 |
| Mehta, AK; Ticku, MK | 1 |
| Atterwill, CK; Brown, CG; Conybeare, G; Holland, CW; Jones, CA | 1 |
| Hashimoto, T; Koda, H; Kuriyama, K | 1 |
| Block, H; Klemm, WR | 1 |
12 other study(ies) available for bromocriptine and Anochlesia
| Article | Year |
|---|---|
Drug design via pharmacophore identification. Dopaminergic activity of 3H-benz[e]indol-8-amines and their mode of interaction with the dopamine receptor.
Topics: Amines; Animals; Catalepsy; Corpus Striatum; Hydroxydopamines; Indoles; Male; Mice; Motor Activity; Optical Rotation; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine | 1986 |
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Behavior, Animal; Blood-Brain Barrier; Brain; Bromocriptine; Catalepsy; Chitosan; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Hypokinesia; Injections, Intravenous; Male; Mice; Nanoparticles; Neurons; Parkinson Disease; Radionuclide Imaging; Random Allocation; Sodium Pertechnetate Tc 99m; Tissue Distribution | 2013 |
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase | 2013 |
On some central effects of elymoclavine.
Topics: Animals; Bromocriptine; Catalepsy; Central Nervous System; Corpus Striatum; Ergolines; Exploratory Behavior; Haloperidol; Humans; Hydroxydopamines; Mice; Oxidopamine; Pimozide; Rats; Receptors, Dopamine; Seizures; Stereotyped Behavior; Sympathetic Nervous System | 1984 |
Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Topics: Animals; Bromocriptine; Carbidopa; Catalepsy; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Motor Activity | 1997 |
Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Catalepsy; Dopamine Agonists; Indoles; Macaca fascicularis; Male; Mice; Oxidopamine; Parkinsonian Disorders; Rats; Reserpine; Tremor | 2000 |
Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
Topics: Animals; Behavior, Animal; Body Temperature; Bromocriptine; Catalepsy; Drug Interactions; Ergolines; Ergotamines; Humans; Male; Mice; Motor Activity; Prochlorperazine; Reserpine; Social Environment; Stereotyped Behavior | 1977 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
Topics: Animals; Aspartic Acid; Baclofen; Bromocriptine; Catalepsy; Dibenzocycloheptenes; Dizocilpine Maleate; Drug Interactions; Haloperidol; Male; N-Methylaspartate; Nimodipine; Nitrendipine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Scopolamine | 1990 |
Relation between dopaminergic control of pituitary lactotroph function and deceleration of age-related changes in serum prolactin of diet-restricted rats.
Topics: Aging; Animals; Bromocriptine; Catalepsy; Diet; Dopamine; Female; Haloperidol; Male; Pituitary Gland; Prolactin; Random Allocation; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1989 |
[Emetic and catalepsy-inducing actions of buflomedil].
Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationship, Drug; Levodopa; Male; Mice; Pyrrolidines; Vomiting | 1988 |
D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Catalepsy; Male; Mice; Molindone; Motor Activity; Receptors, Dopamine | 1988 |